✦ LIBER ✦

496 A phase I dose-escalation study of BI 811283, an Aurora B inhibitor, administered day 1 and 15 every four weeks, in patients with advanced solid tumours

✍ Scribed by M. Scheulen; K. Mross; H. Richly; B. Nokay; A. Frost; D. Scharr; K.H. Lee; O. Saunders; J. Hilbert; O. Fietz

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

27 ORAL Phase I dose escalation study of

✍ M. De Jonge; N. Steeghs; J. Verweij; J.W.R. Nortier; F. Eskens; J. Ouwerkerk; C. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 82 KB

A phase I study of bendamustine hydrochl

✍ Rasschaert, M; Schrijvers, D; Van den Brande, J; Dyck, J; Bosmans, J; Merkle, K; 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 120 KB

Phase I dose-escalation study of vinflun

✍ Calvo, E.; Vermorken, J. B.; Hiret, S.; Rodon, J.; Cortes, J.; Senellart, H.; de 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 242 KB

36 ORAL A Phase I single dose escalation

✍ P. Schöffski; A. Awada; H. Dumez; T. Gil; S. Bartholomeus; J. Selleslach; M. Tat 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 75 KB

413 POSTER A phase I dose escalation stu

✍ W.P. Yong; B.C. Goh; K. Ethirajulu; P. Yeo; O. Otheris; S.M. Chao; R. Soo; W.L. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 61 KB

343 POSTER Phase I dose escalation study

✍ H.A. Burris; G. Hudes; S. Jones; J. Cheng; D. Spigel; M. Mariani; H. Macdonald; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 57 KB